Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

News Roundup: May 26, 2022

Proscia
By Author Proscia | May 26, 2022

Proscia, a digital and computational pathology solutions company, introduced an automated quality control application that leverages artificial intelligence (AI) to improve quality and efficiency in data-driven drug development. The company has also released an updated version of its Concentriq for Research platform to unify global pathology operations further and centralize data across the connected enterprise.

Our website uses cookies. By using this site, you agree to its use of cookies.